IP Library Assignment 025089/0615
Patent Assignment
Reel/Frame 025089/0615

Assignment of Assignor's Interest

Recorded: 2010-10-05 Pages: 3
Assignor
FEINSTEIN, ELENA
Executed: 2008-04-01
Assignee
QUARK PHARMACEUTICALS, INC.
6500 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Property (1)
Oligoribonucleotide Inhibitors of NRF2 and Methods of Use Thereof for Treatment of Cancer
Patent: 7,812,002 →
Application: 12/077,414 →
Publication: US 2009/0215864